Regulation of equine fibrinolysis in blood and peritoneal fluid based on a study of colic cases and induced endotoxaemia
- 1 November 1994
- journal article
- Published by Wiley in Equine Veterinary Journal
- Vol. 26 (6) , 474-481
- https://doi.org/10.1111/j.2042-3306.1994.tb04053.x
Abstract
Much of the pathophysiology associated with equine gastrointestinal diseases is attributed to the effects of endotoxin on haemostasis. Because little is known about the responses of the equine fibrinolytic system to endotoxin, regulation of the system was investigated. Tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor type-1 (PAI-1) were identified as the primary plasminogen activator and plasminogen activator inhibitor, respectively, in equine blood. Under experimental conditions, the equine fibrinolytic system responded to endotoxin in a manner similar to that reported in man, with an early, transient increase in t-PA activity followed by an overwhelming and prolonged increase in activity of PAI-1. To investigate the response of the equine fibrinolytic system to clinical endotoxaemia, endotoxin concentrations were measured in plasma and peritoneal fluid, and activities of t-PA and PAI-1 were compared between healthy horses (n = 38) and horses with naturally occurring gastrointestinal diseases (n = 150). It was observed that plasma PAI-1 and peritoneal t-PA were increased concurrently in abnormal horses; and that these increases were associated with the presence of endotoxin. The results of this study suggest that 1) fibrinolysis is regulated in horses in a manner similar to that in man; 2) regulation of fibrinolysis is altered in endotoxaemic horses with gastrointestinal diseases; 3) events occurring in the vascular system may not reflect those in the peritoneal cavity; and 4) t-PA activity is increased in the peritoneal fluid of endotoxaemic horses with gastrointestinal diseases.Keywords
This publication has 40 references indexed in Scilit:
- Plasminogen Activator Inhibitor Type 1: Biochemistry and Evidence for Modulation of Fibrinolysis In VivoSeminars in Thrombosis and Hemostasis, 1992
- Antithrombin III activity in horses with colic: an analysis of 46 casesEquine Veterinary Journal, 1991
- Abdominal Adhesions after Small Intestinal Surgery in the HorseVeterinary Surgery, 1990
- Activation and inhibition of fibrinolysis in septic patients in an internal intensive care unitBritish Journal of Haematology, 1990
- The effects of slow infusion of a low dosage of endotoxin in healthy horsesEquine Veterinary Journal, 1989
- Promotion and Subsequent Inhibition of Plasminogen Activation after Administration of Intravenous Endotoxin to Normal SubjectsNew England Journal of Medicine, 1989
- Reduced human peritoneal plasminogen activating activity: Possible mechanism of adhesion formationBritish Journal of Surgery, 1989
- Plasminogen activator inhibitor (PAI‐1) in plasma and plateletsBritish Journal of Haematology, 1988
- Tissue Plasminogen ActivatorNew England Journal of Medicine, 1988